Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Lifecare AS ( (DE:LFC0) ) has shared an announcement.
Lifecare ASA has set the subscription price for its partially underwritten rights issue at NOK 0.50 per new share, aiming to raise gross proceeds of between NOK 80 million and NOK 100 million through the issuance of up to 200 million new shares with preferential subscription rights for existing shareholders. The rights issue, subject to approval at an extraordinary general meeting on 2 January 2026, includes tradable subscription rights on Euronext Oslo Børs and grants participating investors additional upside through two series of free warrants, each warrant allowing subscription of one new share at a capped discount to the market price. The structure, including a 35% discount to TERP on the offer price and warrant-based follow-on funding options, underscores Lifecare’s effort to secure capital on shareholder-friendly terms as it advances its sensor technology and continuous glucose monitoring ambitions, potentially strengthening its financial base and market position in the medtech segment.
More about Lifecare AS
Lifecare ASA is a medical sensor company developing technology for sensing and monitoring various body analytes, with a primary focus on bringing next-generation continuous glucose monitoring systems to market. Its osmotic pressure-based sensor platform is designed for use in humans and pets, targeting a wide range of analytes and molecules for real-time health monitoring.
Average Trading Volume: 104,874
Current Market Cap: NOK79.29M
Find detailed analytics on LFC0 stock on TipRanks’ Stock Analysis page.